Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $33.1 million.

  • Arcturus Therapeutics Holdings' Non-Current Assets fell 1679.51% to $33.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.0 million, marking a year-over-year decrease of 496.99%. This contributed to the annual value of $38.1 million for FY2024, which is 1102.96% down from last year.
  • Arcturus Therapeutics Holdings' Non-Current Assets amounted to $33.1 million in Q3 2025, which was down 1679.51% from $34.8 million recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' 5-year Non-Current Assets high stood at $64.4 million for Q3 2023, and its period low was $10.8 million during Q2 2021.
  • In the last 5 years, Arcturus Therapeutics Holdings' Non-Current Assets had a median value of $41.6 million in 2024 and averaged $36.1 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Non-Current Assets soared by 32235.73% in 2022, and later tumbled by 3813.02% in 2024.
  • Arcturus Therapeutics Holdings' Non-Current Assets (Quarter) stood at $13.9 million in 2021, then skyrocketed by 239.67% to $47.1 million in 2022, then decreased by 9.02% to $42.8 million in 2023, then fell by 11.03% to $38.1 million in 2024, then decreased by 12.99% to $33.1 million in 2025.
  • Its Non-Current Assets was $33.1 million in Q3 2025, compared to $34.8 million in Q2 2025 and $53.0 million in Q1 2025.